Abstract
The method of intrapleural Mitoxantrone therapy in case of metastasizing mammary cancer is presented in form of a case report. The uncomplicated procedure, the high rate of remission and the few side effects are the advantages as compared to other methods of pleurodesis. Mitoxantrone could cause an intrapleural inflammatory reaction. That is supported by the cytologic findings before and after the therapy.
MeSH terms
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / pathology
-
Breast Neoplasms / radiotherapy*
-
Carcinoma, Intraductal, Noninfiltrating / drug therapy*
-
Carcinoma, Intraductal, Noninfiltrating / pathology
-
Carcinoma, Intraductal, Noninfiltrating / radiotherapy
-
Combined Modality Therapy
-
Female
-
Humans
-
Injections, Intralesional
-
Mitoxantrone / administration & dosage*
-
Mitoxantrone / adverse effects
-
Neoplasm Staging
-
Pericardial Effusion / drug therapy*
-
Pericardial Effusion / pathology
-
Pericardial Effusion / radiotherapy*
-
Pericardium / drug effects
-
Pericardium / pathology
-
Pericardium / radiation effects
-
Pleura / drug effects
-
Pleura / pathology
-
Pleura / radiation effects
-
Pleural Effusion, Malignant / drug therapy*
-
Pleural Effusion, Malignant / pathology
-
Pleural Effusion, Malignant / radiotherapy*
-
Radiation Injuries / pathology